GAINERS
Alnylam Pharmaceuticals (+6%) : The company’s director Amy W Schulman executed a purchase of 1,910 shares worth $299,526, which lifted its stock.
Steris (+4%): Besides reporting a robust Q2 revenue of $1.6bn, exceeding analysts target of $1.56bn, the medical equipment supplier’s rating…
© MarketScreener.com 2026
Alnylam Pharmaceuticals (+6%) : The company’s director Amy W Schulman executed a purchase of 1,910 shares worth $299,526, which lifted its stock.
Steris (+4%): Besides reporting a robust Q2 revenue of $1.6bn, exceeding analysts target of $1.56bn, the medical equipment supplier’s rating…
© MarketScreener.com 2026